| Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 316 |
| The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies | Clinical and Translational Radiation Oncology | 2018 | 252 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia | Nature Medicine | 2018 | 235 |
| Integration of oncology and palliative care: a Lancet Oncology Commission | Lancet Oncology, The | 2018 | 230 |
| Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 223 |
| Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 207 |
| Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer | JAMA - Journal of the American Medical Association | 2018 | 171 |
| Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study | Annals of Oncology | 2018 | 152 |
| ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 145 |
| International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease | Blood | 2018 | 127 |
| European Society for Medical Oncology (ESMO) position paper on supportive and palliative care | Annals of Oncology | 2018 | 120 |
| Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies | Clinical Cancer Research | 2018 | 116 |
| Immune Cell Composition in Human Non-small Cell Lung Cancer | Frontiers in Immunology | 2018 | 95 |
| Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers | JAMA Oncology | 2018 | 84 |
| Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients | Journal of Pathology | 2018 | 81 |
| Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial | Lancet Haematology,the | 2018 | 76 |
| mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice | Proceedings of the National Academy of Sciences of the United States of America | 2018 | 60 |
| Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM) | Bone Marrow Transplantation | 2018 | 59 |
| Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders | Journal of Allergy and Clinical Immunology | 2018 | 53 |
| Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia | Blood | 2018 | 52 |
| Norwegian reference values for the Short-Form Health Survey 36: development over time | Quality of Life Research | 2018 | 51 |
| Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors | Advances in Urology | 2018 | 51 |
| Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis | Journal of the National Cancer Institute | 2018 | 50 |
| Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors | Cancer Immunology Research | 2018 | 49 |
| CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer | Annals of Oncology | 2018 | 49 |
